Adicet Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Adicet Bio, Inc. (ACET) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents56.50159.71257.66277.5484.33
Short-Term Investments119.810.000.000.0010.28
Cash & Short-Term Investments176.30159.71257.66277.5494.61
Accounts Receivable0.000.000.440.212.73
Inventory0.000.000.000.000.00
Other Current Assets3.830.462.954.682.76
Total Current Assets180.14162.27261.04282.44100.34
Non-Current Assets
Property, Plant & Equipment (Net)36.7544.2048.9835.0025.86
Goodwill0.000.0019.4619.4620.09
Intangible Assets0.000.000.000.001.19
Other Non-Current Assets3.330.821.212.046.36
Total Non-Current Assets40.0845.0269.6556.5053.50
Total Assets220.22207.30330.69338.94153.84
Current Liabilities
Accounts Payable4.832.634.403.261.55
Short-Term Debt3.130.000.000.000.00
Accrued Liabilities4.326.9312.816.685.73
Deferred Revenue0.000.000.004.8113.98
Other Current Liabilities11.436.515.704.023.83
Total Current Liabilities19.3919.2919.7116.3222.48
Non-Current Liabilities
Long-Term Debt14.1017.7018.5319.3820.42
Deferred Tax Liabilities0.000.000.000.000.13
Other Non-Current Liabilities0.120.130.110.120.98
Total Non-Current Liabilities14.2217.8318.6519.4921.53
Total Liabilities33.6137.1238.3535.8144.01
Stockholders' Equity
Common Stock0.010.000.000.000.00
Retained Earnings-497.89-380.77-238.11-168.32-106.33
Accumulated Other Comprehensive Income0.020.000.000.000.02
Additional Paid-in Capital684.48550.94530.45471.45216.13
Shares Outstanding5.162.702.682.480.00
Total Stockholders' Equity186.61170.18292.34303.13109.83
Total Liabilities & Equity220.22207.30330.69338.94153.84